$3.70
6.09% today
Nasdaq, May 21, 08:18 pm CET
ISIN
US42225T1079
Symbol
HCAT

Health Catalyst Inc Target price 2025 - Analyst rating & recommendation

Health Catalyst Inc Classifications & Recommendation:

Buy
69%
Hold
31%

Health Catalyst Inc Price Target

Target Price $8.05
Price $3.94
Potential
Number of Estimates 11
11 Analysts have issued a price target Health Catalyst Inc 2026 . The average Health Catalyst Inc target price is $8.05. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 13 analysts: 9 Analysts recommend Health Catalyst Inc to buy, 4 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Health Catalyst Inc stock has an average upside potential 2026 of . Most analysts recommend the Health Catalyst Inc stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 306.58 334.33
3.60% 9.05%
EBITDA Margin -4.55% 11.99%
69.92% 375.97%
Net Margin -26.06% -18.63%
46.89% 28.52%

13 Analysts have issued a sales forecast Health Catalyst Inc 2025 . The average Health Catalyst Inc sales estimate is

$334m
Unlock
. This is
7.41% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$335m 7.66%
Unlock
, the lowest is
$330m 6.05%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $307m 3.60%
2025
$334m 9.05%
Unlock
2026
$367m 9.71%
Unlock
2027
$407m 10.84%
Unlock
2028
$472m 16.04%
Unlock

13 Analysts have issued an Health Catalyst Inc EBITDA forecast 2025. The average Health Catalyst Inc EBITDA estimate is

$40.1m
Unlock
. This is
612.08% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$41.0m 622.69%
Unlock
, the lowest is
$32.8m 517.83%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $-14.0m 68.83%
2025
$40.1m 401.02%
Unlock
2026
$51.6m 28.63%
Unlock
2027
$67.9m 31.55%
Unlock
2028
$78.0m 14.95%
Unlock

EBITDA Margin

2024 -4.55% 69.92%
2025
11.99% 375.97%
Unlock
2026
14.06% 17.26%
Unlock
2027
16.69% 18.71%
Unlock
2028
16.53% 0.96%
Unlock

9 Health Catalyst Inc Analysts have issued a net profit forecast 2025. The average Health Catalyst Inc net profit estimate is

$-62.3m
Unlock
. This is
22.05% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-54.2m 25.72%
Unlock
, the lowest is
$-69.5m 4.76%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-79.9m 44.98%
2025
$-62.3m 22.05%
Unlock
2026
$-41.0m 34.18%
Unlock
2027
$-22.2m 45.84%
Unlock
2028
$-20.2m 9.23%
Unlock

Net Margin

2024 -26.06% 46.89%
2025
-18.63% 28.52%
Unlock
2026
-11.17% 40.04%
Unlock
2027
-5.46% 51.12%
Unlock
2028
-4.27% 21.79%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -1.15 -0.90
44.98% 21.74%
P/E negative
EV/Sales 1.00

9 Analysts have issued a Health Catalyst Inc forecast for earnings per share. The average Health Catalyst Inc EPS is

$-0.90
Unlock
. This is
21.74% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$-0.78 25.71%
Unlock
, the lowest is
$-1.00 4.76%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-1.15 44.98%
2025
$-0.90 21.74%
Unlock
2026
$-0.59 34.44%
Unlock
2027
$-0.32 45.76%
Unlock
2028
$-0.29 9.38%
Unlock

P/E ratio

Current -3.43 11.17%
2025
-4.40 28.28%
Unlock
2026
-6.68 51.82%
Unlock
2027
-12.33 84.58%
Unlock
2028
-13.59 10.22%
Unlock

Based on analysts' sales estimates for 2025, the Health Catalyst Inc stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.08 3.57%
2025
1.00 7.32%
Unlock
2026
0.91 8.84%
Unlock
2027
0.82 9.79%
Unlock
2028
0.71 13.83%
Unlock

P/S ratio

Current 0.88 36.27%
2025
0.82 6.90%
Unlock
2026
0.75 8.84%
Unlock
2027
0.67 9.79%
Unlock
2028
0.58 13.82%
Unlock

Current Health Catalyst Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Canaccord Genuity
Locked
Locked
Locked May 08 2025
Stifel
Locked
Locked
Locked May 08 2025
Citigroup
Locked
Locked
Locked Apr 25 2025
Keybanc
Locked
Locked
Locked Apr 16 2025
Evercore ISI Group
Locked
Locked
Locked Apr 09 2025
Stephens & Co.
Locked
Locked
Locked Mar 06 2025
RBC Capital
Locked
Locked
Locked Feb 27 2025
Analyst Rating Date
Locked
Canaccord Genuity:
Locked
Locked
May 08 2025
Locked
Stifel:
Locked
Locked
May 08 2025
Locked
Citigroup:
Locked
Locked
Apr 25 2025
Locked
Keybanc:
Locked
Locked
Apr 16 2025
Locked
Evercore ISI Group:
Locked
Locked
Apr 09 2025
Locked
Stephens & Co.:
Locked
Locked
Mar 06 2025
Locked
RBC Capital:
Locked
Locked
Feb 27 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today